Literature DB >> 24238971

CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer.

Shinichiro Yamada1, Mitsuo Shimada2, Tohru Utsunomiya1, Yuji Morine1, Satoru Imura1, Tetsuya Ikemoto1, Hiroki Mori1, Yusuke Arakawa1, Mami Kanamoto1, Shuichi Iwahashi1, Yu Saito1.   

Abstract

BACKGROUND: It has been determined that the chemokine receptor CXC receptor 4 (CXCR4) and its ligand, stromal cell-derived factor 1 (SDF-1), regulate several key processes in a wide variety of cancers. In this study, we investigate the possible role of SDF-1 (noncancerous liver tissue) and CXCR4 in liver metastases of colorectal cancer (CRC).
MATERIALS AND METHODS: Reverse transcription-polymerase chain reaction was performed to examine the expression of SDF-1 in noncancerous liver tissues of 16 CRC patients with liver metastasis and in normal liver tissues of six patients with benign liver disease. We also examined the expression of CXCR4 in cancerous tissues from primary and metastatic tumors.
RESULTS: Using reverse transcription-polymerase chain reaction, CXCR4 expression in metastatic tumors tended to be higher than that in primary tumors (P = 0.16). High CXCR4 expression in a primary tumor was found to be related to an increased lymphatic invasion (P = 0.01), an advanced depth of tumor invasion (P = 0.07), and a decrease in the overall survival rate. The SDF-1 expression observed in noncancerous liver tissues of CRC with liver metastasis was significantly higher than that observed in normal liver tissues of benign liver disease (P < 0.05).
CONCLUSIONS: In CRC with liver metastasis, CXCR4 expression demonstrated associations with local progression, liver metastasis, and poor overall survival.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CXCR4; Colorectal cancer; Liver metastasis; SDF-1

Mesh:

Substances:

Year:  2013        PMID: 24238971     DOI: 10.1016/j.jss.2013.10.030

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Authors:  Fabio Grizzi; Gianluca Basso; Elena Monica Borroni; Tommaso Cavalleri; Paolo Bianchi; Sanja Stifter; Maurizio Chiriva-Internati; Alberto Malesci; Luigi Laghi
Journal:  Inflamm Res       Date:  2018-01-10       Impact factor: 4.575

Review 2.  Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.

Authors:  Haojun Shi; Ji Li; Deliang Fu
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-07       Impact factor: 4.553

3.  Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.

Authors:  Sen Wang; Chuan Zhang; Zhiyuan Zhang; Wenwei Qian; Ye Sun; Bing Ji; Yue Zhang; Chunyan Zhu; Dongjian Ji; Qingyuan Wang; Yueming Sun
Journal:  Cancer Med       Date:  2017-07-26       Impact factor: 4.452

Review 4.  Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.

Authors:  Nicolas Jacquelot; Connie P M Duong; Gabrielle T Belz; Laurence Zitvogel
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

5.  The Role of CXCL12 Axis in Lung Metastasis of Colorectal Cancer.

Authors:  Meng Wang; Xuyang Yang; Mingtian Wei; Ziqiang Wang
Journal:  J Cancer       Date:  2018-10-10       Impact factor: 4.207

6.  Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.

Authors:  Bing Yang; Chun-Shui Pan; Quan Li; Zhu Yang; Feng-Xi Long; Jing-Yu Fan; Chuan-She Wang; Jing-Yan Han; Dong-Xin Tang
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

Review 7.  Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7.

Authors:  Aïssata Aimée Goïta; Dominique Guenot
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

8.  Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer.

Authors:  Yang Li; Hong-Chang Wang; Jin-Shen Wang; Bo Sun; Le-Ping Li
Journal:  FEBS Open Bio       Date:  2020-05-07       Impact factor: 2.693

Review 9.  Cancer stem cells in progression of colorectal cancer.

Authors:  Yujuan Zhou; Longzheng Xia; Heran Wang; Linda Oyang; Min Su; Qiang Liu; Jingguan Lin; Shiming Tan; Yutong Tian; Qianjin Liao; Deliang Cao
Journal:  Oncotarget       Date:  2017-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.